| Product Code: ETC12568663 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Cyprus continued to see significant import shipments of long-acting insulin, with top countries like Greece, Germany, Netherlands, Switzerland, and Vietnam leading the way. Despite moderate concentration indicated by the Herfindahl-Hirschman Index (HHI), the market experienced a strong compound annual growth rate (CAGR) of 10.34% from 2020 to 2024. The growth rate in 2024 alone reached an impressive 13.05%, highlighting a positive trend in the demand for long-acting insulin in Cyprus.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Long Acting Insulin Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Long Acting Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Long Acting Insulin Market - Industry Life Cycle |
3.4 Cyprus Long Acting Insulin Market - Porter's Five Forces |
3.5 Cyprus Long Acting Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Cyprus Long Acting Insulin Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.7 Cyprus Long Acting Insulin Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.8 Cyprus Long Acting Insulin Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
4 Cyprus Long Acting Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Long Acting Insulin Market Trends |
6 Cyprus Long Acting Insulin Market, By Types |
6.1 Cyprus Long Acting Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Long Acting Insulin Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Cyprus Long Acting Insulin Market Revenues & Volume, By Lantus, 2021 - 2031F |
6.1.4 Cyprus Long Acting Insulin Market Revenues & Volume, By Levemir, 2021 - 2031F |
6.1.5 Cyprus Long Acting Insulin Market Revenues & Volume, By Tresiba, 2021 - 2031F |
6.1.6 Cyprus Long Acting Insulin Market Revenues & Volume, By Basaglar, 2021 - 2031F |
6.1.7 Cyprus Long Acting Insulin Market Revenues & Volume, By Toujeo, 2021 - 2031F |
6.2 Cyprus Long Acting Insulin Market, By Delivery Method |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Long Acting Insulin Market Revenues & Volume, By Pen, 2021 - 2031F |
6.2.3 Cyprus Long Acting Insulin Market Revenues & Volume, By Syringe, 2021 - 2031F |
6.2.4 Cyprus Long Acting Insulin Market Revenues & Volume, By Pump, 2021 - 2031F |
6.2.5 Cyprus Long Acting Insulin Market Revenues & Volume, By Pre-filled Device, 2021 - 2031F |
6.3 Cyprus Long Acting Insulin Market, By Patient Type |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Long Acting Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.3.3 Cyprus Long Acting Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.3.4 Cyprus Long Acting Insulin Market Revenues & Volume, By Gestational Diabetes, 2021 - 2031F |
6.4 Cyprus Long Acting Insulin Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Cyprus Long Acting Insulin Market Revenues & Volume, By Solution, 2021 - 2031F |
6.4.3 Cyprus Long Acting Insulin Market Revenues & Volume, By Suspension, 2021 - 2031F |
7 Cyprus Long Acting Insulin Market Import-Export Trade Statistics |
7.1 Cyprus Long Acting Insulin Market Export to Major Countries |
7.2 Cyprus Long Acting Insulin Market Imports from Major Countries |
8 Cyprus Long Acting Insulin Market Key Performance Indicators |
9 Cyprus Long Acting Insulin Market - Opportunity Assessment |
9.1 Cyprus Long Acting Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Cyprus Long Acting Insulin Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.3 Cyprus Long Acting Insulin Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.4 Cyprus Long Acting Insulin Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
10 Cyprus Long Acting Insulin Market - Competitive Landscape |
10.1 Cyprus Long Acting Insulin Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Long Acting Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here